Piramal Pharma receives EIR for manufacturing facility located at Lexington
(13 Apr 2026)

Back
Piramal Pharma announced that US FDA has issued an Establishment Inspection Report (EIR) for its manufacturing facility located at Lexington, (Kentucky, USA) with VAI (Voluntary Action Indicated).

Receipt of said EIR marks successful closure of the inspection.

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew